非小細胞肺がん(NSCLC)療法の世界市場分析:薬別(アリムタ、イレッサ、アバスチン、タルセバ、ジカディア、タグリッソ、ザーコリ、サイラムザ、オプジーボ、アレセンサ)、地域別(北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEA)、セグメント予測、2014 – 2025...市場調査レポートについてご紹介

【英文タイトル】Non-small Cell Lung Cancer (NSCLC) Therapeutics Market Analysis By Drug (Alimta, Iressa, Avastin, Tarceva, Zykadia, Tagrisso, Xalkori, Cyramza, Opdivo, Alecensa), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Non-small Cell Lung Cancer Therapeutics Market Variables, Trends & Scope
3.1 Market Segmentation and Scope
3.1.1 Market driver analysis
3.1.1.1 Strong pipeline
3.1.1.2 Rising prevalence of NSCLC
3.1.2 Market restraint analysis
3.1.2.1 Pricing pressure
3.2 Penetration & Growth Prospects Mapping
3.3 Non-small Cell Lung Cancer Therapeutics Market – PESTLE Analysis
3.4 Industry Analysis – Porter’s
3.5 Non-small Cell Lung Cancer Therapeutics Competitive Scenario, 2015
3.5.1 Competitive landscape: Market position analysis (based on product portfolio, regional presence and strategic initiatives)
Chapter 4 Non-small Cell Lung Cancer Therapeutics: Drug Estimates & Trend Analysis
4.1 Global Non-small Cell Lung Cancer Therapeutics Market: Drug Movement Analysis & Market Share, 2016 & 2025
4.2 Alimta
4.2.1 Alimta market estimates and forecasts, 2014 – 2025 (USD Million)
4.3 Iressa
4.3.1 Iressa market estimates and forecasts, 2014 – 2025 (USD Million)
4.4 Avastin
4.4.1 Iressa market estimates and forecasts, 2014 – 2025 (USD Million)
4.5 Tarceva
4.5.1 Tarceva market estimates and forecasts, 2014 – 2025 (USD Million)
4.6 Zykadia
4.6.1 Zykadia market estimates and forecasts, 2014 – 2025 (USD Million)
4.7 Tagrisso
4.7.1 Tagrisso market estimates and forecasts, 2014 – 2025 (USD Million)
4.8 Xalkori
4.8.1 Xalkori market estimates and forecasts, 2014 – 2025 (USD Million)
4.9 Cyramza
4.9.1 Cyramza market estimates and forecasts, 2014 – 2025 (USD Million)
4.10 Opdivo
4.10.1 Opdivo market estimates and forecasts, 2014 – 2025 (USD Million)
4.11 Alecensa
4.11.1 Alecensa market estimates and forecasts, 2014 – 2025 (USD Million)
Chapter 5 Non-small Cell Lung Cancer Therapeutics: Regional Estimates & Trend Analysis
5.1 Regional Movement Analysis & Market Share, 2016 & 2025
5.2 North America
5.2.1 North America non-small cell lung cancer therapeutics market, by drug, 2014 – 2025 (USD Million)
5.2.2 North America non-small cell lung cancer therapeutics market, by country, 2014 – 2025 (USD Million)
5.2.3 U.S.
5.2.3.1 U.S. non-small cell lung cancer therapeutics market, by drug, 2014 – 2025 (USD Million)
5.2.4 Canada
5.2.4.1 Canada non-small cell lung cancer therapeutics market, by drug, 2014 – 2025 (USD Million)
5.3 Europe
5.3.1 Europe non-small cell lung cancer therapeutics market, by drug, 2014 – 2025 (USD Million)
5.3.2 Europe non-small cell lung cancer therapeutics market, by country, 2014 – 2025 (USD Million)
5.3.3 Germany
5.3.3.1 Germany non-small cell lung cancer therapeutics market, by drug, 2014 – 2025 (USD Million)
5.3.4 UK
5.3.4.1 UK non-small cell lung cancer therapeutics market, by drug, 2014 – 2025 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific non-small cell lung cancer therapeutics market, by drug, 2014 – 2025 (USD Million)
5.4.2 Asia Pacific non-small cell lung cancer therapeutics market, by country, 2014 – 2025 (USD Million)
5.4.3 Japan
5.4.3.1 Japan non-small cell lung cancer therapeutics market, by drug, 2014 – 2025 (USD Million)
5.4.5 China
5.4.5.1 China non-small cell lung cancer therapeutics market, by drug, 2014 – 2025 (USD Million)
5.5 Latin America
5.5.1 Latin America non-small cell lung cancer therapeutics market, by drug, 2014 – 2025 (USD Million)
5.5.2 Latin America non-small cell lung cancer therapeutics market, by country, 2014 – 2025 (USD Million)
5.5.3 Brazil
5.5.3.1 Brazil non-small cell lung cancer therapeutics market, by drug, 2014 – 2025 (USD Million)
5.5.4 Mexico
5.5.4.1 Mexiconon-small cell lung cancer therapeutics market, by drug, 2014 – 2025 (USD Million)
5.6 MEA
5.6.1 MEA non-small cell lung cancer therapeutics market, by drug, 2014 – 2025 (USD Million)
5.6.2 MEA non-small cell lung cancer therapeutics market, by country, 2014 – 2025 (USD Million)
5.6.3 South Africa
5.6.3.1 South Africa non-small cell lung cancer therapeutics market, by drug, 2014 – 2025 (USD Million)
Chapter 6 Competitive Landscape
7.1 GlaxoSmithKline (GSK) Plc
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Product benchmarking
7.1.4 Strategic initiatives
7.2 Novartis
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 AstraZeneca
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 F. Hoffmann-La Roche Ltd
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 Bristol Myers Squibb Company
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 Pfizer, Inc.
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic Initiatives
7.7 Eli Lilly and Company
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic initiatives
7.8 Sanofi
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives


【レポート販売概要】

■ タイトル:非小細胞肺がん(NSCLC)療法の世界市場分析:薬別(アリムタ、イレッサ、アバスチン、タルセバ、ジカディア、タグリッソ、ザーコリ、サイラムザ、オプジーボ、アレセンサ)、地域別(北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEA)、セグメント予測、2014 – 2025
■ 英文:Non-small Cell Lung Cancer (NSCLC) Therapeutics Market Analysis By Drug (Alimta, Iressa, Avastin, Tarceva, Zykadia, Tagrisso, Xalkori, Cyramza, Opdivo, Alecensa), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2014-2025
■ 発行日:2017年3月2日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707595
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。